...12年2月9夜与澳小原亚疫苗启收母司BioDiem无限母司(ASX:BDM)签订了《关于BioDiem无限母司蒙权淌感病毒减毒死疫苗技术(LAIV)给长秋百克生物科技股分母司的和谈》。原主技术蒙权没有需落接母司董事会审议,也没有构成关连接难。
基于8个网页-相关网页
证明这一举措的可行性,San of i Pasteur已在向巴西转让流感疫苗技术方面发挥关键作用,巴西明年将能够生产疫苗。
Attesting to the feasibility of this approach, Sanofi Pasteur has played a key role in transferring influenza vaccine technology to Brazil which will be in a position to produce vaccine next year.
这种疫苗是用非常规的技术生产出来的。
The vaccine had been produced by an unconventional technique.
这些疫苗的技术方法可能略有不同,但它们的目的是相同的。
The technical approaches of these vaccines can be a little different, but their aims are the same.
We talked about attenuating in the laboratory, using cell culture techniques and what we know about mutating viruses.
我们讲过实验室中,利用细胞培养技术培养减毒疫苗,以及我们所了解的减毒病毒
That suggests, now, if you think about this even highly simplified lifecycle, suggests some other ways that we might use kind of modern technologies to engineer new vaccines.
那说明了,如果你,思考下这个高度简化的生命周期,那里隐含着其它一些突破口,即我们可以用某种现代技术,来构建新型疫苗
The Hepatitis B vaccine I talked about before produced by recombinant DNA technologies, called Recombivax HB, that's one version of it.
我曾经提到过的通过DNA重组技术,制造的乙型肝炎疫苗,被称作重组乙型肝炎疫苗,那是该疫苗的型号之一
应用推荐